BioTrinity 2011 participants


See who attended in 2011:

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M  |  N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

 

  • Abbott Biotech Ventures (US)
  • AbD Serotec
  • Abgent Europe
  • Abingworth LLP
  • AB-Therapeutics (Spain)
  • ACM Global Central Laboratory
  • Adaptimmune
  • Advent Venture Partners
  • Aelios Finance (France)
  • Aescap Venture (Netherlands)
  • Affimed Therapeutics AG (Germany)
  • Ajinomoto co., Inc. (Japan)
  • Alacrita
  • Albion Ventures
  • Alchemy Healthcare
  • Allergan
  • Almac
  • Alzprotect (France)
  • Amadeus Capital Partners
  • Amakem NV (Belgium)
  • Ambicare Health
  • A. Menarini IFR (Italy)
  • AMRI
  • Apex Healthcare Consulting
  • Apitope
  • Apposite Capital
  • APTBio Ltd
  • Aptuit, Inc. (US)
  • Aquapharma Discovery
  • Aquarius Equity Partners
  • Arcamis Limited
  • Arrayjet
  • Astex Therapeutics Limited
  • Aston University
  • AstraZeneca
  • APTBio Ltd
  • Atlas Venture (United States)
  • AvantiCell Science
  • Babraham Bioscience Technologies
  • Babraham Institute
  • BASi
  • Baxter Healthcare
  • Begbroke Science Park
  • Bench International
  • BIA
  • Bicycle Therapeutics
  • BigBear Communications
  • Bilcare GCS Europe Ltd
  • Bioalternatives (France)
  • BioCity Nottingham
  • BioDundee
  • BioEdge Pharma Consultancy Ltd
  • BioFocus
  • Bioneer A/S (Denmark)
  • BioPark/BABS Biomarker Services
  • Biopharma Process Systems
  • Biopharm Insight (media)
  • BioProcess Technology Consultants, Inc. (USA)
  • Biopta
  • BioScience Managers Limited
  • Biotech Personnel
  • BiotechSubsidy (Belgium)
  • Biotec Services International
  • Biotrial International
  • BioVex
  • BioWin (Belgium)
  • BiOxyDyn
  • Black Swan Analysis
  • Boehringer Ingelheim Venture Fund (Germany)
  • Boult Wade Tennant
  • Bridgehead International
  • BSG TV
  • Cambridge Enterprise Ltd
  • Cambridge Research Biochemicals
  • Cancer Research Technology Ltd
  • Catalent Pharma Solutions (France)
  • CDSS
  • CellAura Technologies Ltd
  • CellCentric
  • Cellecta Inc. (USA)
  • Cell Medica
  • Cellvax (France)
  • Cellzome
  • Cels NEPAF
  • Celtic Pharma Holdings Advisors LLP
  • CEM Analytical Services
  • Citeline Drug Intelligence
  • Charles River BPS (Germany)
  • Charles Russell LLP
  • Chemistry World (Media)
  • Chempetitive 
  • Chroma Therapeutics
  • Cinetique Translations
  • Citeline Drug Intelligence (Press)
  • Citigate Dewe Rogersen
  • Clinica (media)
  • Clinical Development and Support Services Ltd (CDSS)
  • Clinical Network Services (CNS) Pty Ltd (Australia)
  • Clubb Capital Ltd
  • CMP Therapeutics
  • CMS Cameron McKenna LLP
  • College Hill Life Sciences
  • Collins Stewart Europe
  • Coller IP Management Ltd
  • Colloidal Resource (Sweden)
  • Colworth Science Park
  • Commitum (Sweden)
  • Complix
  • The Communications Strategy Group Inc. (US)
  • Competitive Drug Development International
  • Conformetrix
  • Consultant - Warwick Bryant (Australia)
  • CR Competence
  • Covance Laboratories
  • CR Development
  • Credit Agricole Private Equity (France)
  • Crescendo Biologics
  • Critical Pharmaceuticals
  • CTPartners
  • C-TRIC
  • Cyprotex Discovery plc
  • Cytox
  • CXR BioSciences Ltd
  • CXR Discovery
  • Datum Developments
  • Debiopharm SA (Switzerland)
  • Defined Health (Switzerland)
  • Dehns
  • Delta Partners (Ireland)
  • DestiNA Genomics
  • DFJ Esprit LLP
  • Diligent Consulting
  • Dishman Group
  • Domainex
  • DSM Venturing (Netherlands)
  • Drug Discovery Today (Media)
  • Eagle Genomics
  • EBD Group
  • ECI Partners
  • Edwards Angell Palmer & Dodge
  • Edinburgh Bioquarter
  • Edison Investment Research
  • Edmond de Rothchild Investment Partners (France)
  • EKF Diagnostics (Germany)
  • Eli Lilly
  • Elsevier (Press)
  • Entrepreneurs Fund
  • EpiStem ltd
  • ERA Consulting UK
  • ERGOMED Group
  • Essen Bioscience
  • e-Therapeutics plc
  • ETV Capital
  • Euprotec Ltd
  • Eurobiomed (France)
  • Eurobiomed-Euromediag (France)
  • Eurogentec Biologics (Belgium)
  • EUSA Pharma
  • Evolution Securities
  • Evotec (UK) Ltd
  • Excalibur
  • Fasken Martineau LLP
  • Field Fisher Waterhouse
  • Finance Wales
  • Fisher Scientific
  • FOCUS Insurance
  • Forresters
  • Forbion Capital Partners (Netherlands)
  • Forresters
  • Fosun Pharma (China)
  • Fountain Healthcare Partners
  • Fry Heath Spence
  • Future Injection Technologies
  • Galenica (Sweden)
  • GeneFirst
  • Genetrix SL (Spain)
  • Gen-probe Life Sciences
  • Gentronix
  • george james
  • Gerson Lehrman Group
  • GFA
  • Glysure
  • Grove Lodge Consulting
  • GSK (CEEDD)
  • GxPi
  • Halo BioConsulting Ltd
  • Harlan Laboratories
  • Harrison Clinical Research
  • Harwell Science Park
  • Hays Pharma
  • H20 Venture Partners
  • Health Protection Agency
  • HealthTIES
  • Heptares Therapeutics Ltd
  • High Force Research Ltd
  • HLS
  • HMA Digital Marketing
  • Horton Ruston Poole
  • Horus Security Consultancy
  • ICDD (France)
  • ICON Development Solutions
  • Illetrop Ltd
  • Immunocore
  • Imperial Innovations (Investment side)
  • INC Research 
  • Innaxon
  • Innova Biosciences Ltd
  • Innovacell Biotechnologie AG (Austria)
  • Innovaro Europe
  • Institut Català d'investigació Química
  • Integrated Magnetic Systems
  • Intelligent Pharma (Spain)
  • Interea International
  • International Bioscience Managers
  • International Labmate (Media)
  • Intertek Pharmaceutical Services
  • Inventages
  • Inventages Venture Capital
  • Invest in Skane (Sweden)
  • In Vivo (media)
  • Ion Channel Biotechnology Centre
  • IP Asset Ventures
  • IP Group plc
  • IPSO Ventures
  • IPT Pharma
  • IPT Magazine (Press)
  • IQ Capital Partners LLP
  • Ironwood Pharmaceuticals (US)
  • Isis Innovation
  • Isogenica
  • JA Kemp & Co
  • James Cowper
  • John Innes Centre
  • Jonathan Kwok
  • JPT Peptide Technology GmbH (Germany)
  • Kancera AB (Sweden)
  • Kelly Scientific Resources
  • King's College London
  • KPMG
  • KWS Biotest
  • Lab Support
  • Lacerta Bio BD&L
  • Lacerta Bio Inc. (US)
  • LD Invest Life Science Capital (Denmark)
  • Leiden Bioscience Park Foundation (Netherlands)
  • Liverpool Life Sciences
  • Liverpool Science Park
  • London Economic Development Corporation (Canada)
  • LRM (Belgium)
  • Lumemed
  • Lundbeckfond Ventures
  • Malvern Cosmeceutics
  • Manches LLP
  • Mathys & Squire LLP
  • Matrix Corporate Capital
  • Matrix Group Investment Banking Division
  • McEwen Laboratories
  • M:Communications
  • Medical Delta (Netherlands)
  • MedNous (Press)
  • Melbourn Scientific
  • MEPC Milton Park
  • Mercia Fund Management
  • Mergermarket (FT Group)
  • Merck Serono Ventures (Switzerland)
  • Mergermarket (media)
  • Michelson Diagnostics
  • Midven
  • Mirabaud Securities
  • MODE Diagnostics
  • Molecular Profiles
  • Morningside (China / US)
  • MorphoSys AG
  • MorphoSys UK Ltd T/A AbD Serotec
  • Morrison & Foerster (Germany)
  • MRC Harwell
  • MSD
  • MSD BioManufacturing Network 
  • MP Healthcare Venture Management, Inc. (US)
  • MVM Life Science Partners LLP
  • Myotec Therapeutics
  • NanoSight
  • nanoTherics Ltd
  • Nature (media)
  • Nature Biotechnology (media)
  • NDA Group
  • NeoMed (Switzerland)
  • Neurogenix Ltd
  • Neurotune (Switzerland)
  • New Hill Management
  • Next Control Systems - Tutela
  • Nightingale Associates
  • NovaBiotics Ltd
  • Novartis (USA)
  • Novasep (France)
  • Novella Clinical
  • Novexel (France)
  • Novo A/S (Denmark)
  • NOXXON Pharma AG (Germany)
  • Numerus
  • O2H
  • OBN
  • OCT Consulting (Russian Federation)
  • OctoPlus (Netherlands)
  • One Nucleus
  • OrganOx
  • Orthox
  • ORSETEC
  • Oryzon (Spain)
  • Osborne Clarke
  • Oval Medical Technologies Ltd
  • Oxford BioMedica
  • Oxford Biomedical Research Centre
  • Oxford Brookes University
  • Oxford Capital Partners
  • Oxford Expression Technologies
  • Oxford Gene Technology IP
  • Oxford Nutrascience Ltd
  • Oxford Science Park
  • Oxford Technology Management
  • Partner International Inc. (Canada) 
  • Patheon
  • Paul Capital
  • Peel Hunt
  • Penn Pharma
  • Pera
  • Pfizer (USA)
  • PGXIS
  • Pharmaceutical Project Management Services
  • Pharmafocus (Press)
  • PharmaVentures
  • PharmaWire (media)
  • Pharmovation Ltd
  • Phase4 Ventures
  • PhotoBiotics
  • Phylogica
  • Physiomics plc
  • Pipeline Biotech (Denmark)
  • PiR Interims
  • Piramal Healthcare
  • Pivotal Scientific
  • Plasticell Limited
  • Plasticell Therapeutics
  • Plethora Solutions
  • Ploughshare Innovations
  • PolyTherics
  • Potter Clarkson LLP
  • PRA International
  • PregLem SA (Switzerland)
  • ProCarta Biosystems
  • Pro-Cure Therapeutics
  • ProPharma Partners Limited
  • Prosarix Ltd
  • Prosidion (part of Astellas)
  • Protaffin Biotechnologie (Austria)
  • Protagen AG (Germany) 
  • Providion
  • Proximagen
  • PSI (Ireland)
  • QED Clinical Services
  • Q Chip
  • QSIant
  • Quality Assistance SA (Belgium)
  • Quay Pharmaceuticals
  • Quest Diagnostics Clinical Trials
  • QuickSTAT
  • Quotient Clinical Sciences
  • R5 Pharmaceuticals
  • Rainbow Seed Fund
  • Randox Pharma Services
  • Raquel Hughes
  • Raumedic
  • R&D Focus (Press)
  • Reading Scientific Services
  • RecipharmCobra Biologics
  • Red Moon Executive Search
  • Reed Scientific
  • Regional Economic Development Inc. (US)
  • Regulatory Resources Group Ltd
  • Remtec Search and Selection
  • Ridge & Partners LLP
  • Riverbank IT Management Ltd
  • Roche Pharma Partnering
  • Royal Society Enterprise Fund
  • RSA
  • RSSL Pharma
  • Rules Based Medicine, Inc. (US)
  • SAFC Contract Manufacturing
  • Safeguard Biosystems Holdings Ltd
  • Salusion (Netherlands)
  • Samedan Ltd (Press)
  • SANIFIT Laboratoris (Spain)
  • SANYO E&E Europe BV
  • Satellite
  • sanofi-aventis (France)
  • Saretius
  • SARomics Biostructures Ab (Sweden)
  • Satellite
  • Scancell Holdings plc
  • Science Port Holland (Netherlands)
  • Scientific Laboratory Supplies
  • SCRIP (media)
  • S-cubed
  • Selcia
  • Senectus Therapeutics
  • SEP
  • Sequani Limited
  • Seroba Kernel Life Sciences (Ireland)
  • Serotec
  • Seventure Partners (France)
  • Shanghai Fosun Pharmaceutical (China)
  • Shire plc
  • Shire-Movetis NV (Belgium)
  • Shire Pharmaceuticals
  • Shire Strategic Investment Group
  • Siegfried
  • Silence Therapeutics
  • Simbec Research
  • Singer Capital Markets
  • SmartSensor Telemed
  • Smith & Nephew
  • Sofinnova Partners (France)
  • Solid Form Solutions
  • SPARK Ventures
  • SRA Global Clinical Development
  • SR One
  • SRCL
  • SRG
  • State of Georgia UK Office
  • Stevenage Bioscience Catalyst
  • Stratagem IPM Ltd
  • Sudbrook Associates
  • Sultan Scientific
  • Summit plc
  • Syne qua non
  • Synergy Outsourcing
  • Synergis Technologies
  • Syntaxin Ltd
  • Syntagon (Sweden)
  • Synth-Isis
  • Takeda Pharmaceuticals Europe 
  • Takeda Ventures, Inc. (US)
  • Talentmark
  • Team Consulting
  • Technikos LLP
  • Teva
  • TFS (Sweden)
  • The Communications Strategy Group Inc. (US)
  • The Electrospinning Company
  • The Pink Sheet (media)
  • Theradex Europe
  • The Wellcome Trust
  • TMRI
  • Tissue Solutions Ltd
  • Total Scientific Ltd
  • TranScrip Partners LLP
  • TwistDX Ltd
  • Ubichem Pharma Services
  • UK BioIncubator Forum
  • UKTI
  • UMIC
  • UMIP
  • University of Bradford
  • University of Cambridge
  • University of Dundee
  • University of Edinburgh
  • University of Glasgow
  • University of Missouri (US)
  • University of Oxford
  • University of Southampton - Clinical Neurosciences
  • University of Southampton - Human Development and Health
  • University of Southampton - Infection, Inflammation and Immunity
  • Veeda
  • Ventech (France)
  • Versant EuroVentures (Switzerland)
  • Vertex Pharmaceuticals Europe
  • VWR International
  • Warwick Ventures
  • Wellington Partners (Germany)
  • Western Provident Association
  • WilmerHale
  • World Courier
  • WPA
  • Wragge & Co LLP
  • Wuhan National Bioindustry Base (China)
  • Xention
  • Zealand Pharma (Denmark)




BioTrinity 2014 highlights
1,014 delegates from 32 countries
624 companies
184 speakers
107 company showcase presentations
2,462 one-to-one meetings
130+ investor delegates from 12 countries
61 exhibitors
86 global pharma/medtech delegates
33 corporate venture delegates